51 related articles for article (PubMed ID: 38455592)
1. MYD88 and beyond: novel opportunities for diagnosis, prognosis and treatment in Waldenström's Macroglobulinemia.
Landgren O; Tageja N
Leukemia; 2014 Sep; 28(9):1799-803. PubMed ID: 24573383
[TBL] [Abstract][Full Text] [Related]
2. ST2825, independent of MyD88, induces reactive oxygen species-dependent apoptosis in multiple myeloma cells.
Nakamura H; Arihara Y; Usami M; Takada K
Biochem Biophys Rep; 2024 Jul; 38():101681. PubMed ID: 38455592
[TBL] [Abstract][Full Text] [Related]
3. MYD88 Inhibitor ST2825 Suppresses the Growth of Lymphoma and Leukaemia Cells.
Shiratori E; Itoh M; Tohda S
Anticancer Res; 2017 Nov; 37(11):6203-6209. PubMed ID: 29061802
[TBL] [Abstract][Full Text] [Related]
4. The MyD88 inhibitor, ST2825, induces cell cycle arrest and apoptosis by suppressing the activation of the NF‑κB/AKT1/p21 pathway in pancreatic cancer.
Lu S; He T; Zhang Y; Zhou B; Zhang Q; Yan S
Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37326109
[TBL] [Abstract][Full Text] [Related]
5. Targeting MyD88: Therapeutic mechanisms and potential applications of the specific inhibitor ST2825.
Liu M; Kang W; Hu Z; Wang C; Zhang Y
Inflamm Res; 2023 Nov; 72(10-11):2023-2036. PubMed ID: 37814128
[TBL] [Abstract][Full Text] [Related]
6. Disrupting myddosome assembly in diffuse large B‑cell lymphoma cells using the MYD88 dimerization inhibitor ST2825.
Wang X; Tan Y; Huang Z; Huang N; Gao M; Zhou F; Hu J; Feng W
Oncol Rep; 2019 Nov; 42(5):1755-1766. PubMed ID: 31432184
[TBL] [Abstract][Full Text] [Related]
7. MyD88 dimerization inhibitor ST2825 targets the aggressiveness of synovial fibroblasts in rheumatoid arthritis patients.
Ramirez-Perez S; Vekariya R; Gautam S; Reyes-Perez IV; Drissi H; Bhattaram P
Arthritis Res Ther; 2023 Sep; 25(1):180. PubMed ID: 37749630
[TBL] [Abstract][Full Text] [Related]
8. Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project.
D'Agostino M; Cairns DA; Lahuerta JJ; Wester R; Bertsch U; Waage A; Zamagni E; Mateos MV; Dall'Olio D; van de Donk NWCJ; Jackson G; Rocchi S; Salwender H; Bladé Creixenti J; van der Holt B; Castellani G; Bonello F; Capra A; Mai EK; Dürig J; Gay F; Zweegman S; Cavo M; Kaiser MF; Goldschmidt H; Hernández Rivas JM; Larocca A; Cook G; San-Miguel JF; Boccadoro M; Sonneveld P
J Clin Oncol; 2022 Oct; 40(29):3406-3418. PubMed ID: 35605179
[TBL] [Abstract][Full Text] [Related]
9. ST2825, a Small Molecule Inhibitor of MyD88, Suppresses NF-κB Activation and the ROS/NLRP3/Cleaved Caspase-1 Signaling Pathway to Attenuate Lipopolysaccharide-Stimulated Neuroinflammation.
Zhang SS; Liu M; Liu DN; Shang YF; Wang YH; Du GH
Molecules; 2022 May; 27(9):. PubMed ID: 35566338
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species in cancer: Current findings and future directions.
Nakamura H; Takada K
Cancer Sci; 2021 Oct; 112(10):3945-3952. PubMed ID: 34286881
[TBL] [Abstract][Full Text] [Related]
11. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities.
Abdallah N; Greipp P; Kapoor P; Gertz MA; Dispenzieri A; Baughn LB; Lacy MQ; Hayman SR; Buadi FK; Dingli D; Go RS; Hwa YL; Fonder A; Hobbs M; Lin Y; Leung N; Kourelis T; Warsame R; Siddiqui M; Lust J; Kyle RA; Bergsagel L; Ketterling R; Rajkumar SV; Kumar SK
Blood Adv; 2020 Aug; 4(15):3509-3519. PubMed ID: 32750129
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant Nanotherapies for the Treatment of Inflammatory Diseases.
Li CW; Li LL; Chen S; Zhang JX; Lu WL
Front Bioeng Biotechnol; 2020; 8():200. PubMed ID: 32258013
[TBL] [Abstract][Full Text] [Related]
14. An analysis of the expression and function of myeloid differentiation factor 88 in human osteosarcoma.
Chen J; He J; Yang Y; Jiang J
Oncol Lett; 2018 Oct; 16(4):4929-4936. PubMed ID: 30250559
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]